Bio-Connect
IHC-P analysis of rat brain tissue using GTX32095 PLAGL2 antibody. Working concentration : 2 microg/ml
IHC-P analysis of rat brain tissue using GTX32095 PLAGL2 antibody. Working concentration : 2 microg/ml
IHC-P analysis of rat brain tissue using GTX32095 PLAGL2 antibody. Working concentration : 2 microg/ml

PLAGL2 antibody

GTX32095
GeneTex
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetPLAGL2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    PLAGL2 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1 - 2 microg/mL. IHC-P: 2 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID5326
  • Target name
    PLAGL2
  • Target description
    PLAG1 like zinc finger 2
  • Target synonyms
    ZNF900, zinc finger protein PLAGL2, C2H2-type zinc finger protein, pleiomorphic adenoma gene-like 2, pleiomorphic adenoma-like protein 2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9UPG8
  • Protein Name
    Zinc finger protein PLAGL2
  • Scientific Description
    Pleiomorphic adenoma gene-like 2 is a zinc-finger protein that recognizes DNA and/or RNA. [provided by RefSeq, Jul 2008]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Zheng S, Ni J, Li Y, et al. 2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop. Pharmacol Res. 2021,169:105685. doi: 10.1016/j.phrs.2021.105685
    Read this paper
  • Qian F, Wang J, Wang Y, et al. MiR-378a-3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation. Clin Transl Med. 2021,11(2):e307. doi: 10.1002/ctm2.307
    Read this paper